Lv1
20 积分 2023-11-10 加入
Engineering multi-specific nano-antibodies for cancer immunotherapy
18小时前
已完结
The aryl hydrocarbon receptor: a rehabilitated target for therapeutic immune modulation
2天前
已完结
Immunometabolism in systemic lupus erythematosus
2天前
已完结
Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer
2天前
已完结
New promises and challenges in the treatment of advanced non-small-cell lung cancer
16天前
已完结
Fibrosis: cross-organ biology and pathways to development of innovative drugs
16天前
已完结
Bispecific and multispecific antibodies in oncology: opportunities and challenges
20天前
已完结
The present and future of bispecific antibodies for cancer therapy
20天前
已完结
Rheumatoid arthritis — the role of T cells in this complex systemic autoimmune disease
21天前
已完结
Azobenzene‐Based Linker Strategy for Selective Activation of Antibody–Drug Conjugates
23天前
已完结
皖公网安备34019202002308
